Night-time splinting of the distal interphalangeal joint reduces pain and improves extension at the joint: results from the splint-OA study  by Watt, F.E. et al.
Abstracts / Osteoarthritis and Cartilage 21 (2013) S9–S62 S25Progression of knee OA was measured by change in radiographic joint
space narrowing (JSN) score (deﬁned as any increase in JSN score,
including within-grade changes) between the 24- and 48-month OAI
visits, change in medial-to-lateral peri-articular bone mineral density
ratio at the tibial plateau (M:L paBMD ratio), and change in four MRI
trabecular morphometry measures: apparent bone volume fraction
(aBV/TV), apparent trabecular thickness (aTb.Th), number (aTb.N), and
spacing (aTb.Sp) between baseline and follow-up visits. We used
multivariate logistic or linear regression models to analyze the associ-
ations of serum 25(OH)D and PTH levels with OA progression after
adjusting for age, sex, race, study site, body mass index, dietary and
supplemental intake of vitamin D, and season of blood drawn when
they changed the parameter estimates  10%.
Results: The mean levels of serum 25(OH)D and PTH at baseline were
65. 5 nmol/L and 54.5 pg/mL, respectively. Serum 25(OH) D and PTH
levels were negatively correlated (Pearson r ¼ - 0.29, p<0.0001).
Between the baseline and follow-up visits, 14.1% of the study partici-
pants had an increase in JSN score. The M:L paBMD ratio increased by
0.001 (SD¼0.05). Changes in log-transformed aBV/TV, aTb.Th, aTb.N
and aTb.Sp were -0.02, 0.01 mm, -0.03 mm-1, and 0.04 mm respectively
(SD¼0.35, 0.09, 0.29, and 0.35). Participants with low serum vitamin D
levels (<37.5 nmol/L or 15 ng/ml) had more than two-fold elevated risk
of having an increase in JSN score than those with high vitamin D levels
(37.5 nmol/L; OR¼2.3, 95%CI: 1.1-4.5). Serum PTH level was not
associated with increases in JSN score. Neither serum 25(OH)D nor PTH
was associated with changes in M:L paBMD ratio or changes in
trabecular morphometry.
Conclusion: Low serum level of vitamin D is associated with an
increased risk of progression in joint space narrowing in knees with
OA. Changes in peri-articular tibial bone mineral density and trabec-
ular morphometry were small and not related to vitamin D or PTH
levels.Table 1
Baseline demographic, dietary and behavioral factors by serum levels of 25(OH)D (nmol
Total (N¼488)
Age(yr), mean  SD 63.9  9.1
Female, % 47.1
Non-Hispanic white, % 73.8
Body mass index (kg/m2), mean  SD 29.7  4.6
PASE score, mean  SD 168.1  82.2
Alcohol 1drink/day, % 14.2
Smokers, % 54.8
Dietary and supplemental intake of vitamin D
(IU/day)2, median (Q1-Q3)
257.9 (102.7-444.3)
Users of vitamin D supplement, % 65.4
Winter/spring seasons of blood draw, % 49.8
History of knee injury or surgery, % 58.6
1. P values were calculated from ANOVA (age, body mass index, PASE score), Kruskal-Wall
smoking, supplemental vitamin D use, season of blood draw and history of knee injury
2. Values of vitamin D intake were adjusted for total energy intake.
Table 2
Serum levels of 25(OH)D and PTH in association with OA progression in JSN score1, the O
All subjects (N¼418) Subjects with preexi
Not progress / Progress OR (95%CI)1 Not progress / Progr
25 (OH)D (nmol/L)2
 37.5 308 / 51 1.0 190 / 38
< 37.5 44 / 15 2.3 (1.1-4.5) 28 / 15
PTH (pg/mL)2
< 50 180 / 27 1.0 109 / 24
 50 179 / 32 1.1 (0.6-2.0) 109 / 29
1. OA progression in JSN score is deﬁned any increase in JSN score between baseline and
2. Logistic regression model for serum 25(OH)D and joint space narrowing was adjusted
logistic regression model for serum PTH and joint space narrowing was adjusted for
supplemental intake of vitamin D (400 vs. <400 IU/day).34
NIGHT-TIME SPLINTING OF THE DISTAL INTERPHALANGEAL JOINT
REDUCES PAIN AND IMPROVES EXTENSION AT THE JOINT: RESULTS
FROM THE SPLINT-OA STUDY
F.E. Watt y, D. Kennedy z, K. Carlisle z, A. Freidin y, R. Szydlo x, L.
Honeyﬁeld z, K. Satchithananda z, T.L. Vincent y. yKennedy Inst. of
Rheumatology, Univ. of Oxford, Oxford, United Kingdom; zCharing Cross
Hosp., Imperial Coll., London, United Kingdom; xHammersmith Hosp.,
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Purpose: Distal interphalangeal (DIP) joint osteoarthritis is common
but has few cost-effective, evidence-based interventions. Pain, defor-
mity (radial or ulnar deviation of the joint) and loss of full extension
(extension lag) frequently lead to both functional and cosmetic issues.
Whilst thermoplastic splinting of the ﬁrst carpometacarpal joint is
effective in improving pain, splinting of the interphalangeal joints is not
currently an accepted therapeutic option. We investigated whether
splinting the DIP joint would improve pain, function and deformity.
Methods: A prospective, radiologist-blinded, controlled trial of custom
splinting of the DIP joint was carried out. 26 subjects with symptomatic
hand osteoarthritis gave written, informed consent. All had at least 2
‘affected’ DIP joints (pain2/10 on a numerical rating scale, and at least
7 radial/ulnar deviation +/-extension lag) and were on stable therapies
prior to, and during the study. One intervention joint and one control
joint (which remained un-splinted - there being no satisfactory
placebo) were nominated. Where possible, the contralateral, same digit
DIP joint was the ‘perfect match’ control. A custom ‘gutter’ splint was
worn on consecutive nights (maximum 12 hours/day) for 3 months,
with clinical assessment and measurement of joint deviation (un-
splinted) by digital plain radiograph at baseline and after 3 months.
Statistics: Differences in change in intervention and control joint/L), the Osteoarthritis Initiative, 2007-2009.





64.3  9.1 61.7  9.0 0.02
47.5 45.2 0.72
78.1 49.3 <0.0001
29.3  4.5 31.9  4.7 <0.0001
167.7  82.0 170.5  83.4 0.78
14.5 12.5 0.65
56.1 47.2 0.16




is test (dietary intake of vitamin D) and chi-square test (sex, race/ethnicity, drinking,
or surgery).
steoarthritis Initiative, 2007-2009.
sting OA (N¼271) Subjects without preexisting OA (N¼147)
ess OR (95%CI)1 Not progress / Progress OR (95%CI)1
1.0 118 / 6 1.0
3.2 (1.5-6.8) 23 / 0 –
1.0 71 / 3 1.0
1.1 (0.6-1.2) 70 / 3 0.7 (0.1-4.0)
follow-up visits.
for age (continuous) and supplemental intake of vitamin D (400 vs. <400 IU/day);
age (continuous), BMI (continuous), season (summer/fall vs. winter/spring) and
Abstracts / Osteoarthritis and Cartilage 21 (2013) S9–S62S26outcome measures were compared by Wilcoxon Signed Ranks Test (2-
tailed), ﬁrstly in the whole study population, and secondly the pre-
deﬁned subgroup with contralateral ‘perfect match’ control.
Results: Of 26 subjects, 23 were women, 3 men; mean age was 63 years
(51-78); mean time from diagnosis 6.5 years; mean BMI 26. At baseline,
the median average pain score in the preceding 2 weeks was similar in
the intervention (6/10) and control joints (5/10). 24 subjects completed
the study. A further patient required a hand steroid injection and was
excluded from analysis. The average pain (primary outcome measure)
and worst pain scores in the intervention joint were signiﬁcantly lower
at 3 months compared with baseline (p¼0.002, p¼0.02 respectively).
Change in joint deviation on X-ray (radiologist blinded to intervention
digit) approached, but did not achieve signiﬁcance at 3 months
(p¼0.076). When nominated intervention and control joints were
compared in all 23 patients, differences did not reach signiﬁcance. In
the subgroup who had a contralateral, ‘perfect match’ control digit,
average pain was signiﬁcantly lower in the intervention joint at 3
months (p¼0.035) and extension lag was signiﬁcantly improved
(p¼0.016). However, no signiﬁcant difference in functional outcome
measures, such as active range of motion or pinch grip was evident. 2
serious adverse events occurred during the study period, neither of
which appeared to relate to the intervention.
Conclusions: DIP joint OA can lead to signiﬁcant hand pain, deformity
and disability. Short-term DIP joint splinting is a safe, simple, inex-
pensive treatment modality which reduces DIP joint pain and improves
ability to extend the digit. It does not, if carried out nightly, give rise to
non-compliance, increased stiffness or restriction of range of motion.
The lack of a suitable placebo intervention to which investigator and
patient are blinded is a recognised weakness in this type of study.
Whilst powered to detect a difference in average pain, it is likely thatSNP association results in discovery and replication cohorts.
SNP Effect allele
(Freq)
MrOS/SOF (discovery) RSI RSII GOAL Nottingham
cases/ controls OR (P) cases/ controls OR (P) cases/ controls OR (P) cases/ controls OR (P) cases/ controls OR (P)
rs788748 A (0.49) 662/ 4750 0.71 (2x10-8) 462/ 3428 0.86 (0.03) 149/ 1430 0.98 (0.88) 1291/ 783 0.85 (0.01) 1258/ 758 1.01 (0.83)a larger study population would be required to fully understand effects
of splinting on other secondary outcomes, particularly given the large
ﬂuctuations observed in control joints. Fixed splinting, for longer
periods than 3 months, may have brought about a greater change in
outcomes, albeit with a stiffer joint, but is less likely to be well-toler-
ated. Larger trials would be required to investigate this possibility.35
GENETIC VARIANTS NEAR INSULIN-LIKE GROWTH FACTOR BINDING
PROTEIN 3 (IGFBP3) ARE ASSOCIATED WITH HIP OSTEOARTHRITIS
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Purpose: Hip osteoarthritis (HOA) is one of the most common joint
disorders and can result in pain and disability. HOA is heritable, but the
particular genes contributing to the development of HOA are not well
deﬁned. To identify genetic associations with HOA, we conducted
a two-stage genome-wide association study (GWAS).
Methods: All analyses were restricted to individuals of European
ancestry. The discovery phase was performed using radiographically
determined HOA cases and controls selected from the Osteoporotic
Fractures in Men (MrOS) Study and the Study of Osteoporotic Fractures
(SOF) (combined cases ¼ 662). HOA cases were deﬁned as Croft grade
2 or total hip replacement (THR). HOA controls were deﬁned as Croft
grade  1, maximum joint space narrowing (JSN)  1, maximumosteophytes  1, and no THR. SNPs were genotyped using the Illumina
Omni1-Quad array and approximately 2.5 million SNPs were imputed
using the HapMap reference panel. Logistic regression was performed,
and MrOS and SOF results were combined using inverse variance
weighted ﬁxed effect meta-analysis. SNP associations with P-values 
5x10-8 were examined for replication in the Rotterdam cohorts (RSI ¼
original cohort, RSII ¼ second recruitment cycle) and the GOAL and
Nottingham case-control studies. Publicly available eQTL data from
HapMap CEU lymphoblastoid cell lines were used.
Results: On average, MrOS participants (100% male) were older than
SOF participants (100% female) at the clinic visits when HOA was
assessed (MrOS: meanSD ¼ 77.55.4 years, range ¼ 69-97; SOF:
meanSD ¼ 70.95.0 years, range ¼ 65-91). In the discovery meta-
analysis, the rs788748 A allele and the rs879966 G allele were associ-
ated with decreased odds for HOA (Table 1). The two directly genotyped
SNPs were 23 kb apart and were in moderate LD (HapMap CEU r2 ¼
0.54). Neither SNP remained nominally signiﬁcant in conditional anal-
ysis, indicating dependence. Meta-analysis of the four replication
cohorts indicated that rs788748 was signiﬁcantly associated with HOA
(OR ¼ 0.91, P-value ¼ 0.01, Table 1). From eQTL data, rs788748 and
rs879966 were marginally associated with IGFBP3 expression (P-value
¼ 0.07 and 0.06, respectively), but not IGFBP1 expression (P-value ¼
0.74 and 0.34, respectively). Knockdown of IGFBP3 in the ATDC5
chondrogenesis model system resulted in a reduction of hypertrophic
markers and a reduction in type X collagen, indicating a role for IGFBP3
in chondrogenesis.
Conclusions: Results from our genetic association study and IGFBP3
functional studies provide evidence for a link between IGFBP3 and HOA.
IGFBP3 is known to be expressed in human chondrocytes and might be
an attractive candidate for further follow-up studies.36
DIO2 IS EPIGENETICALLY REGULATED BY CPG METHYLATION IN
ARTICULAR CARTILAGE
W.D. Hollander. LUMC, Leiden, NetherlandsPurpose: Genetic studies have identiﬁed the deiodinase iodothyronine
type II gene (DIO2) as osteoarthritis (OA) susceptibility gene. DIO2 is
required for the conversion of intracellular inactive thyroid hormone
(T4) into active thyroid hormone (T3). During development T3 is
required to induce terminal maturation of growth plate chondrocytes,
leading to cell hypertrophy, extracellular matrix breakdown, minerali-
zation of cartilage and the ﬁnal formation of bone. Striking similarities
between maturating chondrocytes from the growth plate and articular
chondrocytes in OA cartilage have been described. Earlier we have
observed a higher protein expression and allelic imbalance (AI) of DIO2
with the SNP rs225014, which is considered detrimental for the integ-
rity of articular cartilage. In the current study, we set out to investigate
whether this up regulation and AI is modulated epigenetically by CpG
dinucleotide methylation and/or rs225014 genotypes.
Methods: Macroscopically preserved and OA cartilage was sampled
from 48 Caucasian end stage OA patients who underwent total joint
arthroplasty of the knee (N ¼ 21) or hip (N ¼ 27). After bisulphite
treatment of isolated DNA from cartilage, CpG methylation was
measured using Epityper, Sequenom. In total 22 CpG dinucleotides were
interrogated for differential methylation between preserved and OA
cartilage. Conventional RT-qPCR was used to measure gene expression.
To identify functional features a Generalized Linear Mixed Model
(GLMM) was ﬁtted to model DIO2 expression from CpG methylation.
Fixed covariates included joint type, disease status of cartilage and
rs225014 risk allele carriage. To account for inter-individual differences
a random effect for donor was included in the model. For chromatin
immunoprecipitation (ChIP) primary chondrocytes isolated from three
OA patients were expanded for two passages.
